Skip to main content
. 2023 Oct 27;14(6):e01118-23. doi: 10.1128/mbio.01118-23

Fig 3.

Fig 3

In vivo efficacy of human-simulated regimen (HSR) of cefepime/zidebactam in neutropenic murine lung infection model against P. aeruginosa with cefepime/zidebactam MICs > 8 mg/L.